Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.98M | 19.81M | 14.77M | 16.90M | 17.80M |
| Total Receivables | 1.31M | 1.08M | 895.00K | 1.66M | 1.61M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.38M | 3.50M | 2.11M | 1.80M | 1.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.06M | 10.11M | 153.00K | 113.00K | 116.00K |
| Total Current Assets | 31.73M | 34.50M | 17.93M | 20.47M | 20.88M |
|
|
|||||
| Total Current Assets | 31.73M | 34.50M | 17.93M | 20.47M | 20.88M |
| Net Property, Plant & Equipment | 386.00K | 420.00K | 330.00K | 330.00K | 322.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 32.12M | 34.92M | 18.26M | 20.80M | 21.21M |
|
|
|||||
| Total Accounts Payable | 4.11M | 4.24M | 4.28M | 4.60M | 4.61M |
| Total Accrued Expenses | 1.48M | 1.85M | 2.52M | 2.11M | 2.73M |
| Short-term Debt | 20.86M | 20.08M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.42M | 1.42M | 1.40M | 1.39M | 1.38M |
| Total Finance Division Other Current Liabilities | 704.00K | 427.00K | 227.00K | 685.00K | 329.00K |
| Total Other Current Liabilities | 704.00K | 427.00K | 227.00K | 685.00K | 329.00K |
| Total Current Liabilities | 28.58M | 28.00M | 8.43M | 8.79M | 9.04M |
|
|
|||||
| Total Current Liabilities | 28.58M | 28.00M | 8.43M | 8.79M | 9.04M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 20.86M | 20.08M | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.58M | 28.00M | 8.43M | 8.79M | 9.04M |
|
|
|||||
| Common Stock & APIC | 144.69M | 144.40M | 144.24M | 143.84M | 141.21M |
| Retained Earnings | -136.35M | -132.95M | -130.20M | -126.82M | -124.02M |
| Treasury Stock & Other | -4.80M | -4.53M | -4.21M | -5.01M | -5.03M |
| Total Common Equity | 3.54M | 6.92M | 9.83M | 12.01M | 12.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.54M | 6.92M | 9.83M | 12.01M | 12.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.54M | 6.92M | 9.83M | 12.01M | 12.17M |
|
|
|||||